Illinois General Assembly

Previous General Assemblies

Public Act 097-0872


 

Public Act 0872 97TH GENERAL ASSEMBLY

  
  
  

 


 
Public Act 097-0872
 
HB5233 EnrolledLRB097 20167 RPM 65645 b

    AN ACT concerning public health.
 
    Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
 
    Section 5. The Illinois Food, Drug and Cosmetic Act is
amended by changing Sections 2.4, 3.22, 5, and 6 as follows:
 
    (410 ILCS 620/2.4)  (from Ch. 56 1/2, par. 502.4)
    Sec. 2.4. (a) "Drug" means (1) articles recognized in the
official United States Pharmacopoeia - National Formulary,
official Homeopathic Pharmacopoeia of the United States,
United States Dispensatory, or Remington's Practice of
Pharmacy, or any supplement to any of them; and (2) articles
intended for use in the diagnosis, cure, mitigation, treatment
or prevention of disease in man or other animals; and (3)
articles (other than food) intended to affect the structure or
any function of the body of man or other animals; and (4)
articles intended for use as a component of any article
specified in clause (1), (2) or (3); but does not include
devices or their components, parts or accessories.
    (b) "Synthetic drug product" means any product that
contains a substance defined as a controlled substance under
subsections (d) and (e) of Section 204 of the Illinois
Controlled Substances Act. Products approved by the U.S. Food
and Drug Administration for human consumption are not synthetic
drug products.
(Source: P.A. 84-891.)
 
    (410 ILCS 620/3.22)  (from Ch. 56 1/2, par. 503.22)
    Sec. 3.22. (a) Whoever knowingly distributes, or possesses
with intent to distribute, human growth hormone for any use in
humans other than the treatment of a disease or other
recognized medical condition, where the use has been authorized
by the Secretary of Health and Human Services and under the
order of a physician, is guilty of a Class 3 felony, and may be
fined an amount not to exceed $50,000. As used in this Section,
the term "human growth hormone" means somatrem, somatropin, or
an analogue of either of them.
    (b) Whoever distributes, or possesses with intent to
distribute, a synthetic drug product or a drug that is
misbranded under this Act is guilty of a Class 2 felony and may
be fined an amount not to exceed $100,000. A person convicted
of a second or subsequent violation of this Section is guilty
of a Class 1 felony, the fine for which shall not exceed
$250,000.
    (c) Whoever falsely advertises a synthetic drug product is
guilty of a Class 3 felony and may be fined an amount not to
exceed $100,000.
    (d) Whoever commits any offense set forth in this Section
and the offense involves an individual under 18 years of age is
punishable by not more than 10 years imprisonment, and twice
the fine authorized above. Any conviction for a violation of
this Section shall be considered a violation of the Illinois
Controlled Substances Act for the purposes of forfeiture under
Section 505 of such Act. As used in this Section the term
"human growth hormone" means somatrem, somatropin, or an
analogue of either of them. The Department of State Police and
Department of Professional Regulation are authorized to
investigate offenses punishable by this Section.
    (e) Any person convicted under this Section is subject to
the forfeiture provisions set forth in subsections (c), (d),
(e), (f), (g), (h), and (i) of Section 3.23 of this Act.
(Source: P.A. 87-754.)
 
    (410 ILCS 620/5)  (from Ch. 56 1/2, par. 505)
    Sec. 5. (a) A person who violates any of the provisions of
this Act, other than Sections 3.22 and 6, is guilty of a Class
C misdemeanor; but if the violation is committed after a
conviction of such person under this Section has become final,
the person shall be guilty of a Class A misdemeanor. A person
who violates the provisions of Section 6 of this Act is guilty
of a Class A misdemeanor; but if the violation is committed
after a conviction of such person under this Section has become
final, the person shall be guilty of a Class 4 felony.
    (b) No person is subject to the penalties of subsection (a)
of this Section for (1) violating Section 3.1 or 3.3 if he
establishes a guaranty or undertaking signed by and containing
the name and address of the person residing in the State of
Illinois from whom he received the article in good faith, to
the effect that the article is not adulterated or misbranded
within the meaning of this Act, designating this Act; or (2)
for having violated clause (2) of Section 3.16 if such person
acted in good faith and had no reason to believe that the use
of the punch, die, plate, stone or other thing involved would
result in a drug being a counterfeit drug, or for having
violated clause (3) of Section 3.16 if the person doing the act
or causing it to be done acted in good faith and had no reason
to believe that the drug was a counterfeit drug.
    (c) No publisher, radio-broadcast licensee, agency or
medium for the dissemination of an advertisement, except the
manufacturer, packer, distributor or seller of the article to
which a false advertisement relates is liable under this
Section for the dissemination of such false advertisement
unless he has refused on the request of the Director to furnish
the Director the name and post office address of the
manufacturer, packer, distributor, seller or advertising
agency residing in the State of Illinois who causes him to
disseminate such advertisement.
    (d) No person shall be subject to the penalties of
subsection (a) of this Section for a violation of Section 3
involving misbranded food if the violation exists solely
because the food is misbranded under subsection (c) of Section
11 because of its advertising, and no person shall be subject
to the penalties of subsection (a) of this Section for such a
violation unless the violation is committed with the intent to
defraud or mislead.
(Source: P.A. 86-704; 87-754.)
 
    (410 ILCS 620/6)  (from Ch. 56 1/2, par. 506)
    Sec. 6. (a) When an authorized agent of the Director finds
or has probable cause to believe that any food, drug, device or
cosmetic is adulterated or so misbranded as to be dangerous or
fraudulent within the meaning of this Act, or is in violation
of Section 12, 17 or 17.1 of this Act, or is suspected to be a
synthetic drug product, he or she shall affix to such article a
tag or other appropriate marking giving notice that the article
is or is suspected of being adulterated or misbranded and has
been detained or embargoed and warning all persons not to
remove or dispose of such article by sale or otherwise until
permission for removal or disposal is given by such agent or
the court. It is unlawful for any person to remove or dispose
of such detained or embargoed article by sale or otherwise
without such permission.
    (b) When an article detained or embargoed under subsection
(a) of this Section is found by such agent to be adulterated or
misbranded or to be in violation of Section 12, 17 or 17.1 of
this Act or is suspected to be a synthetic drug product, he or
she shall petition the circuit court in whose jurisdiction the
article is detained or embargoed for a libel for condemnation
of such article. When such agent finds that an article so
detained or embargoed is not adulterated or misbranded or is
not a synthetic drug product, he or she shall remove the tag or
other marking.
    (c) If the court finds that a detained or embargoed article
is adulterated or misbranded, such article shall, after entry
of the judgment, be destroyed at the expense of the claimant
thereof, under the supervision of such agent, and all court
costs and fees, and storage and other proper expenses, shall be
taxed against the claimant of such article or his or her agent.
However, when the adulteration or misbranding can be corrected
by proper labeling or processing of the article, the court,
after entry of the judgment and after such costs, fees and
expenses have been paid and a good and sufficient bond,
conditioned that such article shall be so labeled or processed,
has been executed, may by order direct that such article be
delivered to the claimant thereof for such labeling or
processing under the supervision of an agent of the Director.
The expense of such supervision shall be paid by the claimant.
The article shall be returned to the claimant and the bond
shall be discharged on the representation to the court by the
Director that the article is no longer in violation of this
Act, and that the expenses of such supervision have been paid.
    (d) Whenever the Director or any of his or her authorized
agents finds in any room, building, vehicle of transportation
or other structure, any meat, sea food, poultry, vegetable,
fruit or other perishable articles which contain any filthy,
decomposed or putrid substance, or that may be poisonous or
deleterious to health or otherwise unsafe, the same being
hereby declared to be a nuisance, the Director or his or her
authorized agent shall condemn or destroy the same, or in any
other manner render the same unusable as human food.
(Source: P.A. 85-564.)
 
    Section 10. The Illinois Controlled Substances Act is
amended by changing Section 204 as follows:
 
    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
    Sec. 204. (a) The controlled substances listed in this
Section are included in Schedule I.
    (b) Unless specifically excepted or unless listed in
another schedule, any of the following opiates, including their
isomers, esters, ethers, salts, and salts of isomers, esters,
and ethers, whenever the existence of such isomers, esters,
ethers and salts is possible within the specific chemical
designation:
        (1) Acetylmethadol;
        (1.1) Acetyl-alpha-methylfentanyl
    (N-[1-(1-methyl-2-phenethyl)-
    4-piperidinyl]-N-phenylacetamide);
        (2) Allylprodine;
        (3) Alphacetylmethadol, except
    levo-alphacetylmethadol (also known as levo-alpha-
    acetylmethadol, levomethadyl acetate, or LAAM);
        (4) Alphameprodine;
        (5) Alphamethadol;
        (6) Alpha-methylfentanyl
    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
    propanilido) piperidine;
        (6.1) Alpha-methylthiofentanyl
    (N-[1-methyl-2-(2-thienyl)ethyl-
    4-piperidinyl]-N-phenylpropanamide);
        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
        (7.1) PEPAP
    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
        (8) Benzethidine;
        (9) Betacetylmethadol;
        (9.1) Beta-hydroxyfentanyl
    (N-[1-(2-hydroxy-2-phenethyl)-
    4-piperidinyl]-N-phenylpropanamide);
        (10) Betameprodine;
        (11) Betamethadol;
        (12) Betaprodine;
        (13) Clonitazene;
        (14) Dextromoramide;
        (15) Diampromide;
        (16) Diethylthiambutene;
        (17) Difenoxin;
        (18) Dimenoxadol;
        (19) Dimepheptanol;
        (20) Dimethylthiambutene;
        (21) Dioxaphetylbutyrate;
        (22) Dipipanone;
        (23) Ethylmethylthiambutene;
        (24) Etonitazene;
        (25) Etoxeridine;
        (26) Furethidine;
        (27) Hydroxpethidine;
        (28) Ketobemidone;
        (29) Levomoramide;
        (30) Levophenacylmorphan;
        (31) 3-Methylfentanyl
    (N-[3-methyl-1-(2-phenylethyl)-
    4-piperidyl]-N-phenylpropanamide);
        (31.1) 3-Methylthiofentanyl
    (N-[(3-methyl-1-(2-thienyl)ethyl-
    4-piperidinyl]-N-phenylpropanamide);
        (32) Morpheridine;
        (33) Noracymethadol;
        (34) Norlevorphanol;
        (35) Normethadone;
        (36) Norpipanone;
        (36.1) Para-fluorofentanyl
    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
    4-piperidinyl]propanamide);
        (37) Phenadoxone;
        (38) Phenampromide;
        (39) Phenomorphan;
        (40) Phenoperidine;
        (41) Piritramide;
        (42) Proheptazine;
        (43) Properidine;
        (44) Propiram;
        (45) Racemoramide;
        (45.1) Thiofentanyl
    (N-phenyl-N-[1-(2-thienyl)ethyl-
    4-piperidinyl]-propanamide);
        (46) Tilidine;
        (47) Trimeperidine;
        (48) Beta-hydroxy-3-methylfentanyl (other name:
    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
    N-phenylpropanamide).
    (c) Unless specifically excepted or unless listed in
another schedule, any of the following opium derivatives, its
salts, isomers and salts of isomers, whenever the existence of
such salts, isomers and salts of isomers is possible within the
specific chemical designation:
        (1) Acetorphine;
        (2) Acetyldihydrocodeine;
        (3) Benzylmorphine;
        (4) Codeine methylbromide;
        (5) Codeine-N-Oxide;
        (6) Cyprenorphine;
        (7) Desomorphine;
        (8) Diacetyldihydromorphine (Dihydroheroin);
        (9) Dihydromorphine;
        (10) Drotebanol;
        (11) Etorphine (except hydrochloride salt);
        (12) Heroin;
        (13) Hydromorphinol;
        (14) Methyldesorphine;
        (15) Methyldihydromorphine;
        (16) Morphine methylbromide;
        (17) Morphine methylsulfonate;
        (18) Morphine-N-Oxide;
        (19) Myrophine;
        (20) Nicocodeine;
        (21) Nicomorphine;
        (22) Normorphine;
        (23) Pholcodine;
        (24) Thebacon.
    (d) Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following
hallucinogenic substances, or which contains any of its salts,
isomers and salts of isomers, whenever the existence of such
salts, isomers, and salts of isomers is possible within the
specific chemical designation (for the purposes of this
paragraph only, the term "isomer" includes the optical,
position and geometric isomers):
        (1) 3,4-methylenedioxyamphetamine
    (alpha-methyl,3,4-methylenedioxyphenethylamine,
    methylenedioxyamphetamine, MDA);
        (1.1) Alpha-ethyltryptamine
    (some trade or other names: etryptamine;
    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
    3-(2-aminobutyl)indole; a-ET; and AET);
        (2) 3,4-methylenedioxymethamphetamine (MDMA);
        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
    (also known as: N-ethyl-alpha-methyl-
    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
    and MDEA);
        (2.2) N-Benzylpiperazine (BZP);
        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
        (4) 3,4,5-trimethoxyamphetamine (TMA);
        (5) (Blank);
        (6) Diethyltryptamine (DET);
        (7) Dimethyltryptamine (DMT);
        (7.1) 5-Methoxy-diallyltryptamine;
        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
        (9) Ibogaine  (some trade and other names:
    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
    indole; Tabernanthe iboga);
        (10) Lysergic acid diethylamide;
        (10.1) Salvinorin A;
        (10.5) Salvia divinorum (meaning all parts of the plant
    presently classified botanically as Salvia divinorum,
    whether growing or not, the seeds thereof, any extract from
    any part of that plant, and every compound, manufacture,
    salts, isomers, and salts of isomers whenever the existence
    of such salts, isomers, and salts of isomers is possible
    within the specific chemical designation, derivative,
    mixture, or preparation of that plant, its seeds or
    extracts);
        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
        (12) Peyote (meaning all parts of the plant presently
    classified botanically as Lophophora williamsii Lemaire,
    whether growing or not, the seeds thereof, any extract from
    any part of that plant, and every compound, manufacture,
    salts, derivative, mixture, or preparation of that plant,
    its seeds or extracts);
        (13) N-ethyl-3-piperidyl benzilate (JB 318);
        (14) N-methyl-3-piperidyl benzilate;
        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
    (also known as N-hydroxy-alpha-methyl-
    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
        (15) Parahexyl; some trade or other names:
    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
    dibenzo (b,d) pyran; Synhexyl;
        (16) Psilocybin;
        (17) Psilocyn;
        (18) Alpha-methyltryptamine (AMT);
        (19) 2,5-dimethoxyamphetamine
    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
        (20) 4-bromo-2,5-dimethoxyamphetamine
    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
    4-bromo-2,5-DMA);
        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
    Some trade or other names: 2-(4-bromo-
    2,5-dimethoxyphenyl)-1-aminoethane;
    alpha-desmethyl DOB, 2CB, Nexus;
        (21) 4-methoxyamphetamine
    (4-methoxy-alpha-methylphenethylamine;
    paramethoxyamphetamine; PMA);
        (22) (Blank);
        (23) Ethylamine analog of phencyclidine.
    Some trade or other names:
    N-ethyl-1-phenylcyclohexylamine,
    (1-phenylcyclohexyl) ethylamine,
    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
        (24) Pyrrolidine analog of phencyclidine. Some trade
    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
    PHP;
        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
        (26) 2,5-dimethoxy-4-ethylamphetamine
    (another name: DOET);
        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
    (another name: TCPy);
        (28) (Blank);
        (29) Thiophene analog of phencyclidine (some trade
    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
    2-thienyl analog of phencyclidine; TPCP; TCP);
        (30) Bufotenine (some trade or other names:
    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
    3-(2-dimethylaminoethyl)-5-indolol;
    5-hydroxy-N,N-dimethyltryptamine;
    N,N-dimethylserotonin; mappine);
        (31)  1-Pentyl-3-(1-naphthoyl)indole 
    Some trade or other names: JWH-018; 
        (32) 1-Butyl-3-(1-naphthoyl)indole 
    Some trade or other names: JWH-073;  
        (33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- 
    (2-iodophenyl)methanone 
    Some trade or other names: AM-694;
        (34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-
    (2-methyloctan-2-yl)phenol 
    Some trade or other names: CP 47,497 47, 497
    and its C6, C8 and C9 homologs;
        (34.5) (33) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- 
    (2-methyloctan-2-yl)phenol), where side chain n=5;  
    and homologues where side chain n=4, 6, or 7;  Some  
    trade or other names: CP 47,497; 
        (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
    (2-methyloctan-2-yl)-6a,7, 
    10,10a-tetrahydrobenzo[c]chromen-1-ol
    Some trade or other names: HU-210; 
        (35.5) (34) (6aS,10aS)-9-(hydroxymethyl)-6,6- 
    dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
    tetrahydrobenzo[c]chromen-1-ol, its isomers,  
    salts, and salts of isomers; Some trade or other  
    names: HU-210, Dexanabinol; 
        (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
    6,6-dimethyl-3-(2-methyloctan-2-yl)- 
    6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
    Some trade or other names: HU-211;
        (37) (2-methyl-1-propyl-1H-indol-
    3-yl)-1-naphthalenyl-methanone 
    Some trade or other names: JWH-015;
        (38) 4-methoxynaphthalen-1-yl-
    (1-pentylindol-3-yl)methanone 
    Some trade or other names: JWH-081;
        (39) (1-Pentyl-3-(4-methyl-1-naphthoyl)indole
    Some trade or other names: JWH-122;
        (40) 2-(2-methylphenyl)-1-(1-pentyl-
    1H-indol-3-yl)-ethanone 
    Some trade or other names: JWH-251;
        (41) 1-(2-cyclohexylethyl)-3- 
    (2-methoxyphenylacetyl)indole 
    Some trade or other names: RCS-8, BTW-8 and SR-18; . 
        (42) (33) Any compound structurally derived from 
    3-(1-naphthoyl)indole or 1H-indol-3-yl- 
    (1-naphthyl)methane by substitution at the 
    nitrogen atom of the indole ring by alkyl, haloalkyl, 
    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
    2-(4-morpholinyl)ethyl whether or not further 
    substituted in the indole ring to any extent, whether 
    or not substituted in the naphthyl ring to any extent; 
        (43) (34) Any compound structurally derived from 
    3-(1-naphthoyl)pyrrole by substitution at the nitrogen 
    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 
    cycloalkylmethyl, cycloalkylethyl or 
    2-(4-morpholinyl)ethyl, whether or not further 
    substituted in the pyrrole ring to any extent, whether 
    or not substituted in the naphthyl ring to any extent; 
        (44) (35) Any compound structurally derived from 
    1-(1-naphthylmethyl)indene by substitution 
    at the 3-position of the indene ring by alkyl, haloalkyl, 
    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
    2-(4-morpholinyl)ethyl whether or not further 
    substituted in the indene ring to any extent, whether 
    or not substituted in the naphthyl ring to any extent; 
        (45) (36) Any compound structurally derived from 
    3-phenylacetylindole by substitution at the 
    nitrogen atom of the indole ring with alkyl, haloalkyl, 
    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
    2-(4-morpholinyl)ethyl, whether or not further 
    substituted in the indole ring to any extent, whether 
    or not substituted in the phenyl ring to any extent; 
        (46) (37) Any compound structurally derived from 
    2-(3-hydroxycyclohexyl)phenol by substitution 
    at the 5-position of the phenolic ring by alkyl, 
    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl 
    or 2-(4-morpholinyl)ethyl, whether or not substituted 
    in the cyclohexyl ring to any extent; . 
        (47) (33) 3,4-Methylenedioxymethcathinone 
    Some trade or other names: Methylone; 
        (48) (34) 3,4-Methyenedioxypyrovalerone 
    Some trade or other names: MDPV; 
        (49) (35) 4-Methylmethcathinone 
    Some trade or other names: Mephedrone; 
        (50) (36) 4-methoxymethcathinone; 
        (51) (37) 4-Fluoromethcathinone; 
        (52) (38) 3-Fluoromethcathinone; . 
        (53) (35) 2,5-Dimethoxy-4-(n)-propylthio- 
    phenethylamine; 
        (54) (36) 5-Methoxy-N,N-diisopropyltryptamine; . 
        (55) Pentedrone. 
    (e) Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following
substances having a depressant effect on the central nervous
system, including its salts, isomers, and salts of isomers
whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation:
        (1) mecloqualone;
        (2) methaqualone; and
        (3) gamma hydroxybutyric acid.
    (f) Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following
substances having a stimulant effect on the central nervous
system, including its salts, isomers, and salts of isomers:
        (1) Fenethylline;
        (2) N-ethylamphetamine;
        (3) Aminorex (some other names:
    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
    4-5-dihydro-5-phenyl-2-oxazolamine) and its
    salts, optical isomers, and salts of optical isomers;
        (4) Methcathinone (some other names:
    2-methylamino-1-phenylpropan-1-one;
    Ephedrone; 2-(methylamino)-propiophenone;
    alpha-(methylamino)propiophenone; N-methylcathinone;
    methycathinone; Monomethylpropion; UR 1431) and its
    salts, optical isomers, and salts of optical isomers;
        (5) Cathinone (some trade or other names:
    2-aminopropiophenone; alpha-aminopropiophenone;
    2-amino-1-phenyl-propanone; norephedrone);
        (6) N,N-dimethylamphetamine (also known as:
    N,N-alpha-trimethyl-benzeneethanamine;
    N,N-alpha-trimethylphenethylamine);
        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
        (8) 3,4-Methylenedioxypyrovalerone (MDPV).
    (g) Temporary listing of substances subject to emergency
scheduling. Any material, compound, mixture, or preparation
that contains any quantity of the following substances:
        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
    (benzylfentanyl), its optical isomers, isomers, salts,
    and salts of isomers;
        (2) N-[1(2-thienyl)
   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
   its optical isomers, salts, and salts of isomers.
(Source: P.A. 96-347, eff. 1-1-10; 96-1285, eff. 1-1-11;
97-192, eff. 7-22-11; 97-193, eff. 1-1-12; 97-194, eff.
7-22-11; 97-334, eff. 1-1-12; revised 9-14-11.)
 
    Section 15. The Drug Paraphernalia Control Act is amended
by changing Section 2 as follows:
 
    (720 ILCS 600/2)  (from Ch. 56 1/2, par. 2102)
    Sec. 2. As used in this Act, unless the context otherwise
requires:
    (a) The term "cannabis" shall have the meaning ascribed to
it in Section 3 of the Cannabis Control Act, as if that
definition were incorporated herein.
    (b) The term "controlled substance" shall have the meaning
ascribed to it in Section 102 of the Illinois Controlled
Substances Act, as if that definition were incorporated herein.
    (c) "Deliver" or "delivery" means the actual, constructive
or attempted transfer of possession, with or without
consideration, whether or not there is an agency relationship.
    (d) "Drug paraphernalia" means all equipment, products and
materials of any kind, other than methamphetamine
manufacturing materials as defined in Section 10 of the
Methamphetamine Control and Community Protection Act, which
are intended to be used unlawfully in planting, propagating,
cultivating, growing, harvesting, manufacturing, compounding,
converting, producing, processing, preparing, testing,
analyzing, packaging, repackaging, storing, containing,
concealing, injecting, ingesting, inhaling or otherwise
introducing into the human body cannabis or a controlled
substance in violation of the Cannabis Control Act, the
Illinois Controlled Substances Act, or the Methamphetamine
Control and Community Protection Act or a synthetic drug
product or misbranded drug in violation of the Illinois Food,
Drug and Cosmetic Act. It includes, but is not limited to:
        (1) kits intended to be used unlawfully in
    manufacturing, compounding, converting, producing,
    processing or preparing cannabis or a controlled
    substance;
        (2) isomerization devices intended to be used
    unlawfully in increasing the potency of any species of
    plant which is cannabis or a controlled substance;
        (3) testing equipment intended to be used unlawfully in
    a private home for identifying or in analyzing the
    strength, effectiveness or purity of cannabis or
    controlled substances;
        (4) diluents and adulterants intended to be used
    unlawfully for cutting cannabis or a controlled substance
    by private persons;
        (5) objects intended to be used unlawfully in
    ingesting, inhaling, or otherwise introducing cannabis,
    cocaine, hashish, or hashish oil, or a synthetic drug
    product or misbranded drug in violation of the Illinois
    Food, Drug and Cosmetic Act into the human body including,
    where applicable, the following items:
            (A) water pipes;
            (B) carburetion tubes and devices;
            (C) smoking and carburetion masks;
            (D) miniature cocaine spoons and cocaine vials;
            (E) carburetor pipes;
            (F) electric pipes;
            (G) air-driven pipes;
            (H) chillums;
            (I) bongs;
            (J) ice pipes or chillers;
        (6) any item whose purpose, as announced or described
    by the seller, is for use in violation of this Act.
(Source: P.A. 93-526, eff. 8-12-03; 94-556, eff. 9-11-05.)
 
    Section 99. Effective date. This Act takes effect upon
becoming law.

Effective Date: 7/31/2012